Clinical Trial

Multimodal AI for Precision Diagnosis of Esophageal Cancer

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This study intends to construct two multimodal deep learning models: one for the diagnosis of esophageal cancer and the prediction of invasive depth to assess suitability for endoscopic resection; the other model, based on this, classifies endoscopic non-resectable patients into different degrees of invasion to further explore the differences in the sensitivity and survival of AI-predicted benign and malignant tumors in patients' responses to NAT, thereby providing reliable decision support for precise individualized treatment. This aspect has rarely been addressed in previous studies.
Trial Details
NCT Number NCT07629921
Lead Sponsor Shanghai Zhongshan Hospital
Conditions Esophageal Cancer
Enrollment 264 participants
Start Date 2023-03-01
Primary Completion 2026-01-01 (estimated)
Study Completion 2026-06-07 (estimated)
Updated on ClinicalTrials.gov 2026-06-05